Dr. Khandros will remain on the board of directors of Nutcracker Therapeutics, and Cynthia Collins will serve as executive ...
In another lightning round JP Morgan interview, editor-in-chief Jonah Comstock caught up with Sam Deutsch, CEO of Nutcracker Therapeutics, to talk briefly about the company’s lead asset for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results